CCRC - Certified Clinical Research Coordinator Study and Site Management Questions and Answers

Question 1

A Clinical Research Coordinator (CRC) at a busy site discovers that a blood sample required for a key secondary endpoint, scheduled for the Week 4 visit, was missed for a participant who has already left the clinic.
The protocol's visit window for this draw has now passed.
How should the CRC best manage and document this situation?

Accepted Answer

Document the event as a protocol deviation and report it to the investigator and, if required, the sponsor/CRO.

Answer

Ask the participant to return immediately, even though it is outside the protocol-defined window, to ensure the data is collected.

Answer

Ignore the missed sample since it is for a secondary, not primary, endpoint.

Answer

Wait until the next scheduled visit to draw the sample and label it as the Week 4 sample to complete the case report form.

Question 2

Which of the following is the most appropriate and GCP-compliant method for a Principal Investigator (PI) to document the assignment of study-related tasks to qualified site staff?

Accepted Answer

A signed and dated Delegation of Authority (DoA) Log specifying tasks, start/end dates, and staff qualifications.

Answer

A verbal agreement made with each staff member during a team meeting.

Answer

An email from the PI to the sponsor listing the names of the research team members.

Answer

A single note-to-file written by the CRC after the study has been completed, summarizing who did what.

Question 3

During a site close-out visit, the Clinical Research Coordinator (CRC) and the monitor are reconciling the investigational product (IP) accountability records. What is the primary purpose of this reconciliation?

Accepted Answer

To ensure all IP units were correctly dispensed, returned to the sponsor, or appropriately destroyed, accounting for every unit received.

Answer

To determine the final payment owed to the site for dispensing the IP.

Answer

To identify which participants were most compliant with the treatment regimen for the final study report.

Answer

To finalize the recruitment statistics for the study based on the number of participants who received IP.

Question 4

A new investigational product (IP) shipment is scheduled to arrive. The protocol specifies the IP must be stored between 2-8°C. The CRC notes that the temperature monitoring device for the site's drug storage refrigerator has not been calibrated in over a year. What is the most critical immediate action for the CRC?

Accepted Answer

Notify the sponsor/CRO and arrange for an immediate calibration of the device before accepting the IP shipment.

Answer

Relocate the new IP shipment to a standard breakroom refrigerator temporarily.

Answer

Accept the shipment and begin recording the temperatures manually every hour with a standard thermometer.

Answer

Proceed with dispensing IP to participants as scheduled from existing stock.

Question 5

Which of the following documents is essential to have completed, signed, and filed in the site's regulatory binder BEFORE a clinical trial can be initiated at the site?

Accepted Answer

A signed and dated FDA Form 1572.

Answer

The final, signed clinical study report.

Answer

A log of all participants who have successfully completed the study.

Answer

A record of all Serious Adverse Event reports submitted to the sponsor.

Question 6

To ensure an efficient interim monitoring visit where the primary purpose is source data verification (SDV), which of the following is the most important preparatory task for the CRC?

Accepted Answer

Ensure all source documents are complete, organized, and readily accessible for the subjects being monitored.

Answer

Schedule all upcoming participant visits for the day the Clinical Research Associate (CRA) is on-site.

Answer

Wait for the CRA to arrive to ask what data needs to be entered into the electronic data capture (EDC) system.

Answer

Prepare a detailed summary of recruitment and retention challenges for the sponsor.